The regular consumption of a polyphenol-rich apple does not influence endothelial function: a randomised double-blind trial in hypercholesterolemic adults by Scalbert, Augustin et al.
The regular consumption of a polyphenol-rich apple
does not influence endothelial function: a randomised
double-blind trial in hypercholesterolemic adults
Augustin Scalbert, Sylvain Auclair, Gilles Chironi, Dragan Milenkovic, Peter
C.H. Hollman, Catherine M.G.C. Renard, Jean-Louis Me´gnien, Je´roˆme
Gariepy, Jean-Louis Paul, Alain Simon
To cite this version:
Augustin Scalbert, Sylvain Auclair, Gilles Chironi, Dragan Milenkovic, Peter C.H. Hollman, et
al.. The regular consumption of a polyphenol-rich apple does not influence endothelial function:
a randomised double-blind trial in hypercholesterolemic adults. European Journal of Clinical
Nutrition, Nature Publishing Group, 2010, <10.1038/ejcn.2010.135>. <hal-00563104>
HAL Id: hal-00563104
https://hal.archives-ouvertes.fr/hal-00563104
Submitted on 4 Feb 2011
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
  1
The regular consumption of a polyphenol-rich apple does not influence endothelial 
function: a randomised double-blind trial in hypercholesterolemic adults 
 
 
Sylvain Auclaira, Gilles Chironid, Dragan Milenkovica, Peter C.H. Hollmanb, Catherine 
M.G.C. Renardc, Jean-Louis Mégniend, Jérôme Gariepyd, Jean-Louis Paule, Alain Simond, 
Augustin Scalberta* 
 
aUnité de Nutrition Humaine, UMR1019, INRA, Centre de Recherche de Clermont Ferrand / Theix, 
63122 Saint-Genès-Champanelle, France 
bRIKILT-Institute of Food Safety, Wageningen University and Research Center, PO Box 230, 6700 
AE, Wageningen, The Netherlands 
cUR117, Recherches Cidricoles et Biotransformation des Fruits et Légumes, INRA, F-35653 Le Rheu, 
France. 
dAP-HP, European Georges Pompidou Hospital, Center of Cardiovascular Preventive Medicine, René 
Descartes University, Paris, France 
eAP-HP, Hopital European Georges Pompidou, Laboratoire de Biochimie, Paris F-75015, France 
 
Running title: Polyphenol-rich apple and endothelial function 
 
 
 
* To whom correspondence should be addressed: 
Scalbert Augustin 
Unité de Nutrition Humaine UMR1019 
INRA-Clermont Ferrand / Theix 
63122 Saint Genès Champanelle 
Tel: +33-4-73-62-47-87 
Fax: +33-4-73-62-46-38 
scalbert@clermont.inra.fr 
  2
Abstract 
 
Background/objectives: Epidemiological studies suggest that apple consumption is associated to a 
reduction of cardiovascular disease risk. Apple polyphenols may contribute to explain these effects. 
Endothelial dysfunction has been associated with early stage of atherosclerosis and polyphenols from 
various dietary sources have been shown to reverse it. The aim of the present study was to investigate 
the effect of the consumption of a polyphenol-rich apple on endothelial function. 
Subjects/methods: Thirty hypercholesterolemic volunteers were included in a doubled-blinded 
randomized cross-over trial. They successively consumed 40 g of two lyophilised apples, polyphenol-
rich and polyphenol-poor, providing respectively 1.43 and 0.21 g polyphenols per day during two 4-
week periods separated by a 4-week washout period. 
Results: Brachial artery flow-mediated dilation (FMD) was assessed at the beginning and at the end of 
each intervention period. FMD did not differ between the polyphenol-rich and the polyphenol-poor 
apples, neither other cardiovascular disease risk factors (plasma lipids, homocysteine, antioxidant 
capacity). 
Conclusions: These data suggest that over a 4-week period, the consumption of a polyphenol-rich 
apple does not improve vascular function in hypercholesterolemic patients. 
 
 
 
 
Keywords: apple, polyphenols, atherosclerosis, FMD 
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1. Introduction 
A high consumption of fruit and vegetables have commonly been associated to a reduction of 
the risk of cardiovascular diseases (Dauchet et al., 2009, Ellingsen et al., 2008). The consumption of 
plant foodstuff was shown to reduce cholesterolemia, oxidative stress, homocysteinemia, endothelial 
dysfunction and blood pressure (Chopra et al., 2000, Dauchet et al., 2009, Silaste et al., 2003). In 
Western countries apples account for an important part of the fruit intake and their consumption were 
shown, in a human intervention study, to increase the plasma antioxidant capacity and uric acid levels 
(Lotito and Frei 2004). Moreover, apple consumption has been associated with a reduced risk of 
cardiovascular diseases in the Women’s Health Study since women ingesting apples had a 13-22% 
decrease in cardiovascular disease risk (Sesso et al., 2003). Animal studies revealed that the 
consumption of apples exerts antioxidant effects (Leontowicz et al., 2002), inhibits lipid oxidation 
(Pearson et al., 1999) and lowers cholesterolemia (Aprikian et al., 2001, Leontowicz et al., 2002). 
Mechanisms involved in these protective effects can be attributed to their content in fibers as well as 
their content in polyphenols which are known to have preventive effects against cardiovascular 
diseases. Indeed, in a Finish study examining the link between flavonoid intake and coronary 
mortality, intake of flavonols with apple and teas as main contributors was inversely correlated with 
coronary mortality in women (Knekt et al., 1996). In addition, in another study examining the impact 
of the consumption of flavonoid-rich foods, apples and pears were found to be associated with a 
decreased coronoary heart disease and cardiovascular disease mortality (Mink et al., 2007).  
Endothelial dysfunction is associated with early stages of atherosclerosis and can be detected before 
before the formation of atherosclerotic plaques notably by measuring the endothelium-dependent flow-
mediated vasodilation (FMD) (Celermajer et al., 1993, Craiem et al., 2007). Endothelial dysfunction is 
characterized by a decreased NO bioavailability and an enhancement of oxidative stress (Celermajer et 
al., 1994, Heitzer et al., 2001). Several studies have shown that brachial FMD is impaired by 
cardiovascular risk factors such as aging, male sex, smoking, hypercholesterolemia and diabetes 
mellitus, and is correlated with invasive coronary results  (Anderson et al., 1995, Celermajer et al., 
1996, Chironi et al., 2008, Levenson et al., 2001). Moreover, brachial FMD is widely accepted to be a 
marker of cardiovascular disease risk (Kuvin and Karas 2003, Verma et al., 2003). A recent meta-
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analysis of randomized-controlled trials with flavonoid-rich foods showed an improvement of 
endothelial function, assessed by flow-mediated vasodilation, and a reduced blood pressure following 
chronic intake of chocolate or cocoa (Hooper et al., 2008). Acute and chronic (4 weeks) black tea 
consumption were able to reverse endothelial dysfunction assessed by an improvement of FMD 
measurements (Duffy et al., 2001). The aim of the present study was to assess the effect of the 
consumption of two apple cultivars with different polyphenol contents, on the cardiovascular function 
notably by measuring the FMD and other linked cardiovascular parameters. 
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2. Methods 
2.1. Materials 
 Cider apple fruits (Malus domestica Borkh.) from the Marie Ménard variety were harvested at 
maturity during the 2002 season in the experimental orchard of the Centre Technique des Productions 
Cidricoles (Sées, Orne, France). Golden delicious apples were obtained from a local wholesale 
grocery. They were drained and rapidly frozen prior to freeze-drying and ground. Polyphenols were 
measured by HPLC after thioacidolysis (Guyot et al., 2001). The average degree of polymerisation 
was measured by calculating the molar ratio of all flavan-3-ol units (thioether adducts plus terminal 
units) to (-)-epicatechin and (+)-catechin terminal units. Nitrogen was analysed by the Kjeldahl 
method and protein was calculated as N x 6.25 . Cell walls were quantified as alcohol insoluble solids 
from the freeze-dried apple powders (Renard 2005). Starch was quantified by an enzymic-colorimetric 
method (Missang et al., 2001). Sugars (glucose, fructose and sucrose), and L-malic acid were 
determined by kit enzymatic assays (Boehringer, Mannheim and R-Biopharm AG, Darmstadt) 
according to producer's specifications.  
The fiber content was determined as the sum of constituting sugars estimated as alditol acetate by GC 
(Massiot and Renard 1997). The composition of the apple powders was balanced for simple sugars and 
dietary fibers, by addition of fructose ("La Vie Claire", Chaponost, France) to Marie Ménard powder 
and of icing sugar (St Louis Sucre, Paris, France, containing 97% saccharose and 3% starch), soluble 
apple fiber (POMELITE LV, Val-de-Vire Bioactives, Condé sur Vire, France) and insoluble cellulose 
(Avicel GP1030, FMC Biopolymers, Newark, USA) to Golden delicous powder. The Marie Ménard 
(20 g, HP) and Golden delicious (19.3 g, LP) apple powders were packed in sealed watertight bags. 
Powder weights in bags were determined in order to provide identical quantities of fibers and simple 
sugars in both groups. Apples were freeze-dried so that they could be more easily transported and 
stored by the patients. Patients could thus leave the hospital at each visit with the 70 bags needed for a 
full experimental period (equivalent to about 70 apples). Very homogenous products were thus 
obtained. The ease of transport also contributed to the good compliance. 
  
2.2. Study design 
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 Thirty hypercholesterolemic men (total cholesterol > 6.2 mmol/L or LDL cholesterol > 4.1 
mmol/L, with a mean age of 52.6 ± 5.5 y, a mean body mass index of 25.7 ± 2.6), without any 
cardiovascular diseases history and without hypocholesterolemic treatment for at least for 6 weeks, 
were included in the study. Exclusion criteria were as follows: familial homozygous 
hypercholesterolemia or LDL cholesterol > 6.2 mmol/L, diabetes (fasting blood glucose at or above 
7mmol/L), hypertension (BP > 180mmHg), renal dysfunction (glomerular filtration < 60mL/min), 
alcohol addiction (> 3 glasses/day), current heavy smoking (Fragerström test > 6) and an excessive 
intake of other polyphenol-rich foods or beverages (coffee, wine, tea, soy). Volunteers were informed 
of the purpose and risks of the study and a written consent was obtained. 
 Investigators were blinded with regard to the nature of the apple samples. The study design 
was a double-blinded crossover. Patients received for two successive 4-week periods (4.3 ± 0.7 weeks) 
either the polyphenol-rich (HP) or the polyphenol-poor (LP) lyophilized apple with a 4-week washout 
(4.6 ± 3.2 weeks) period in-between. Patients made 4 visits, at the beginning and at the end of each 
experimental period (figure 1). At the first visit, they were given the exact number of apple bags 
required for 5 weeks. Unused bags were returned at the following visit and counted to check for 
compliance. Patients were asked to consume 2 bags of lyophilized apples per day, corresponding 
approximately to two fresh apples of 135 g each and maintained their usual diet during the whole 
study. The content of the two bags were consumed, one in the morning and one in the evening, after 
suspending the freeze-dried powder in half-a-glass of water. Blood samples were collected at the 
beginning and at the end of each experimental period, just before FMD measurements on either 
citrated or heparinized tubes. Plasma and serum fractions were prepared, aliquoted and stored at -80°C 
until further analysis. Spot urine samples were collected in the morning of each visit before FMD 
measurements and stored at -80°C. 
 
2.2. Vascular function assessment 
 Endothelial-dependant flow-mediated dilation and endothelium-independent glyceryl 
trinitrate-mediated dilation were assessed at each of the four visits following the protocol previously 
described (Chironi et al., 2008, Craiem et al., 2007). Patients were examined in the morning, after 12 h 
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fasting, in a quiet and temperature controlled room (20±1°C). Dilatation response analysis was 
calculated as the ratio between the maximum change in diameter and baseline diameter and was 
expressed as a percentage change of the baseline diameter, as previously described (Craiem et al., 
2007).  
 
2.3. Biochemical analyses 
 Glycemia, lipids, apolipoproteins, HDL-C and LDL-C were measured in the serum using 
standard laboratory procedures (Fournier et al., 2003, Mweva et al., 2006). Urinary creatinine was 
determined using a commercial kit (ref: 61162 Créatinine Cinétique, Biomérieux, Marcy-l’Etoile, 
France) and a Kone automated apparatus (Progress Plus, Konelab, Thermo-Electron SA). Optical 
density was measured at 492 nm between 20-80 seconds and quality controls were also included in the 
analysis. (Unitrol, ref. 62 321, Biomérieux, Marcy-l’Etoile, France). Homocysteine was estimated in 
plasma as previously described (Blacher et al., 1998). 
Ascorbic acid was determined in deproteinized plasma by HPLC (Tessier et al., 1996). α-
Tocopherol was estimated in plasma by reverse-phase HPLC (Simon et al., 2000). The ferric reducing 
ability of plasma (FRAP) was determined in plasma using the Benzie and Strain method (Benzie and 
Strain 1996). The oxygen radical absorbance capacity (ORAC) was determined on plasma samples 
(Huang et al., 2002). Nitroso compounds [NOx; = NO, NO2-, and nitrosated and nitrosylated species 
(RNOs/ RSNOs)] were estimated by reductive release of NO with an iodide/triiodide containing 
reaction mixture and estimation of the NO formed by chemiluminescence (Appeldoorn et al., 2009). 
Phloretin content in urine was quantified by HPLC-ESI-MS-MS (Ito et al., 2005). 
 
2.5. Statistical analysis 
Data are presented as mean ± SD. Statistical tests were performed with SAS (SAS version 8.1, SAS 
Institute, Cary, NC). Values were log transformed before statistical analysis to compensate for unequal 
variance. The effects of treatment and treatment order were compared by two-way repeated measures 
ANOVA using SAS proc MIXED. SAS LSmeans function was used as post hoc means comparison 
test.
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3. Results 
3.1. Baseline characteristics 
Thirty volunteers were included in this study with a mean age of 52.6 ± 5.5 years, a mean body mass 
index of 25.7 ± 2.6, systolic blood pressure was 123.2 ± 11 mmHg and diastolic blood pressure was 
75.5 ± 7.6 mmHg.  
3.2. Compliance 
Compliance was assessed by measuring phloretin excretion in urine. Phloretin is a dihydrochalcone 
characteristic of apple and has been used as a marker of apple consumption (Mennen et al., 2006). 
Phloretin excretion in urine increased after apple consumption from 0.04-0.11 to 0.52-0.78 nmol/mg 
creatinine (P < 0.01). The difference in phloretin excretion levels between the two apple cultivars at 
the end of the supplementation (HP/LP ratio = 1.5) precisely reflected the difference in phloretin 
content in the two apples (Table 1; HP/LP ratio = 1.6). The exact duration of the periods of apple 
consumption was 4.3 ± 0.9 weeks for the HP apple and 4.2 ± 0.3 weeks for LP apple. The patients 
were asked to consume two apple bags per day. The number of bags actually consumed per day, 
calculated from the number of non-consumed returned bags, was 58.8 ± 9 bags for the HP period and 
59.2 ± 7.7 bags for the LP period showing a good compliance of the subjects. 
3.2. Brachial artery responses 
As shown in table 1, no significance difference in FMD was observed between the LP and HP apples 
after one month of apple supplementation. No difference could neither be observed between baseline 
level at the beginning of each intervention period and the end of the apple supplementation period. 
Figure 2 shows the flow-mediated dilation variability for the 30 patients before and after consuming 
the HP and LP apples. Apple consumption did not influence the endothelium-independent glyceryl-
trinitrate vasodilation. 
3.3. Biochemical parameters 
Consumption of the two apple cultivars during 4 weeks had no significant effect on all measured 
biochemical parameter such as lipids, glucose, antioxidant vitamin status or plasma antioxidant 
capacity (table 2). However, an increase in vitamin C concentration in plasma from 58 µM at baseline 
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to 65 µM was observed after one month of apple consumption, whatever the nature of the apple 
consumed.  
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4. Discussion 
The aim of this study was to assess the impact of the consumption of two apple varieties differing by 
their polyphenol content, on endothelial function and associated cardiovascular parameters. Volunteers 
were asked to consume 40 g of lyophilized apples per day corresponding to the consumption of about 
two apples per day. The patients ingested 214 mg polyphenols per day with the Golden Delicious (LP) 
apple and 1.43 g polyphenols per day with the Marie-Ménard (HP) apple, hence a difference of 
polyphenol intake of 1.21 g per day for the two apples. Compliance was assessed by measuring levels 
of apple phloretin in urine. A good compliance was observed as shown by the increase in phloretin 
excretion at the end of each intervention period. 
The study was carried out in hypercholesterolemic patients known to have an impaired endothelial 
function (Maas et al., 2008). A baseline value of 5-6% for FMD was measured in our subjects (Table 
2). This value is similar to that measured by other groups, and significantly lower than the ~10% value 
commonly observed in normocholesterolemic subjects. Cut-off values for FMD or cholesterolemia at 
baseline, to observe effects on fasting FMD were determined in two meta-analyses. Cut-off for FMD 
was found to be less than 7% for intervention studies with arginine (Bai et al., 2009). Cut-off for 
cholesterolemia was found to be more than 228 mg/dL (Li et al., 2010), a value compatible with the 
mild hypercholesterolemia of the present patients (6.4 mmol/L or 247 mg/dL; Table 2). 
Flow-mediated vasodilation measured at the end of each intervention period did not differ between the 
HP and LP apples, neither any of the other cardiovascular disease risk factors estimated (Table 2). The 
power of the study would have been sufficient to detect a FMD difference of 2.3 percent units (for a 
power of 0.8 and a p value of 0.05), a value higher than the largest (non significant) difference 
between the groups (1.8 % for the difference between baseline and HP apple). In agreement with these 
data, NO did not change between treatments. Fifteen trials in which the effects of flavanoids or 
flavonoid-rich foods and beverages on FMD were examined, were recently analyzed in a meta-
analysis (Hooper et al., 2008). Different results were observed depending in particular on the structure 
of the flavonoids. Only chocolate and tea, both rich in flavanols were shown to increase FMD in 
chronic studies lasting for more than two weeks. However, chronic studies on red wine or grape also 
rich in flavanols did not show any improvement of FMD. Improvement of FMD with flavanol-rich 
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foods or beverages could be explained by either proanthocyanidins or the catechins which are 
systematically associated in these foods. Also, two FMD studies have been carried out with pure 
flavanols. An acute intake of either pure epicatechin (1 or 2 mg/kg body weight in one dose) or 
epigallocatechin gallate (EGCG; one dose of 300 mg) were shown to increase FMD in young healthy 
adults in the two hours following ingestion (Schroeter et al., 2006, Widlansky et al., 2007). However, 
in a similar study with EGCG, the chronic administration of the same dose (300 mg/day) during two 
weeks failed to influence vascular reactivity (Widlansky et al., 2007). In the present work, the intake 
of flavanol monomers was 17 mg/day for the LP apple and 111 mg per day for HP apple consumption. 
This level of intake might have induced a positive effect on FMD as observed in the Schroeter study 
(Schroeter et al., 2006). The lack of effect might therefore be explained by the too rapid elimination of 
flavanol monomers as suggested in the EGCG study. Similarly to this last study, FMD measurements 
were made in the morning about ten hours after consumption of the last apple bag. Catechin 
monomers if responsible for these effects would not be present anymore due to their rapid elimination 
(half-life of 2-3 hrs) (Manach et al., 2005b). However, this interpretation does not fit with the results 
of another chronic study on tea (Duffy et al., 2001). The regular consumption of black tea (900 
ml/day) during 4 weeks still improved FMD measured one night after the last tea intake. 
Another interpretation might also explain the lack of effects of apple polyphenols observed here. 
Catechins in the apple powder might have been less well absorbed than catechins ingested as aqueous 
solutions due to interactions with the apple matrix. Tea catechins were shown to be better absorbed 
after an overnight fast on an empty stomach than when taken with foods resulting in a 3.5 fold 
increase of maximum plasma concentration of free epigallocatechin (Chow et al., 2005). 
The main polyphenols consumed with the apples were procyanidins (Table 1). It is known that their 
bioavailability is low due to their high molecular weight (Déprez et al., 2001, Donovan et al., 2002, 
Gonthier et al., 2003). Only procyanidin dimers have been detected in human plasma but at very low 
concentrations (Holt et al., 2002). Their poor bioavailability does not exclude systemic effects. 
However, few authors have examined the in vivo biological effects of pure proanthocyanidins. Most 
often, their activity was tested using complex proanthocyanidin extracts which also contain catechin 
monomers. These catechin monomers might be responsible for the effects observed (Schroeter et al., 
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2006). Proanthocyanidins are also degraded in the colon into well absorbed low molecular weight 
phenolic acids which may exert systemic effects (Rios et al., 2003). The present study suggests that 
they do not influence vascular reactivity. Due to the relatively long exposure of procyanidins to the 
microbiota in the colon and slow degradation into phenolic acids, the plasma concentrations of their 
phenolic acid metabolites do not vary much over time (Rios et al., 2003). In contrast to catechins, they 
would still be present in the plasma in the morning following consumption of the last apple bag. The 
rapid elimination of catechins proposed to explain the lack of observed effects of the HP apple on 
FMD could not hold for phenolic acids which would therefore be truly inactive. Another FMD study 
with a cocoa drink regularly consumed over one week and providing about 900 mg flavanols per day 
showed an increase of FMD building up over the week, but FMD measurement was carried out 2 hrs 
after consumption of the cocoa drink (Heiss et al., 2007). Two longer-term studies have been carried 
out with flavanol-rich cocoa. The first one showed no effect of the consumption of flavanol-rich cocoa 
during 6 weeks on FMD (Farouque et al., 2006) and the second one only showed a modest effect  of 
the chronic consumption of cocoa  when measured in fasting conditions as in the present study (Balzer 
et al., 2008). 
No effect of a regular HP apple consumption on plasma antioxidant capacity or uric acid concentration 
was observed here. In a review of 12 intervention studies assessing the impact of the consumption of 
different polyphenol-rich foods or beverages during 1 to 12 weeks, no systematic improvement of 
plasma antioxidant capacity, uric acid concentration or in the status of antioxidant vitamins (vitamin C 
and E) could be observed (Manach et al., 2005a). No more consistent effect could be observed on lipid 
oxidation products or LDL oxidizability, also possibly explained by the too rapid elimination of 
polyphenols during the night prior to the collection of fasting plasma samples. The slight increase (x 
1.1) in plasma vitamin C observed here for the two apple varieties when compared to baseline is most 
likely explained by the presence of vitamin C in apples. No effect of the HP apple on blood pressure 
could be observed. Quercetin, one of its phenolic constituents, was shown to reduce blood pressure in 
hypertensive subjects at a dose of 150 mg/day (Egert et al., 2009). The lack of effects observed here is 
most likely explained by the much lower intake of quercetin (about 12 mg/day). 
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This study may be limited by the lack of analysis of the kinetics of brachial artery dilation in response 
to hyperheaemia (Chironi et al., 2008), which could not be studied due to the unavailability of the 
entire FMD time-course curve for some patients. However, the percentage change of FMD between 
baseline and maximal brachial artery diameter as measured here remains the gold standard for 
assessing endothelial function in clinical trials. 
Another limitation of this study is the freeze-dried state of the apples. This contributed to the good 
compliance of the protocol but it may also have influenced the bioavailability of the polyphenols. 
Although the bioavailability of polyphenols in fresh and freeze-dried fruits has not been compared, 
there is no indication that these would differ substantially. The bioavailability of organic acids of fresh 
and freeze-dried banana or sweet potato were compared in a recent publication, and no effect of 
freeze-drying could be seen (Sabboh-Jourdan et al., 2010). Freeze-dried fruits are also commonly used 
in animal studies with no notable effects on polyphenol bioavailability (Felgines et al., 2007). 
Altogether, this first study comparing the effects of a polyphenol-rich and a polyphenol-poor fruit on 
FMD showed no improvement of the endothelial function after consuming the polyphenol-rich apple 
during one month. This result differs from several previous similar studies on endothelial function 
with cocoa or tea in which two foods or beverages differing in their flavanol content were compared. 
However an acute effect on endothelial function in the few hours following ingestion cannot be 
excluded and should be examined. The present study was focused on apple polyphenols. However 
some effects of other apple constituents like fibers or vitamin C on endothelial function cannot be 
excluded (Brock et al., 2006; Ting et al., 1997) and should also be further explored. 
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Table 1 Composition of the two apple cultivars 
Composition (mg/bag)1 
 
Golden Delicious 
(LP) 
Marie-Ménard 
(HP) 
Fibers 3928 2 3866 
   
Polyphenols   
   
    Procyanidins 78 521 
   
    Hydroxycinnamic acids 
                         Caffeoylquinic 10 121 
                         p-Coumaroylquinic 1 5 
   
    Flavan-3-ol monomers 
                         Epicatechin 8 52 
                         Catechin traces 3 
   
    Dihydrochalcones   
                         Phloridzin 4.4 5.6 
                         Phloretin xyloglucoside 2.9 6.8 
   
     Flavonols   
                         Hyperoside 0.6 1.9 
                         Avicularin n.d 1.9 
                         Reynoutrin 0.1 0.9 
                         Quercitrin 0.1 0.6 
                         Isoquercitrin n.d 0.6 
                         Quercetin 0.2 n.d 
                         Rutin traces n.d 
   
Nitrogen 39 40
   
Starch 19 600
   
Sugars   
    Glucose 1737 1660 
    Fructose 7797 3 7520 4 
    Sucrose 3821 3740 5 
   
Malic acid 386 220 
n.d, not dectected 
1 LP and HP bags contain respectively 19.3 and 20.0 g freeze-dried powders. 
2 Balanced by the addition of 2000mg apple fibers per bag. 
3 Balanced by the addition of 2200 mg fructose. 
4 Balanced by the addition of 1100 mg fructose. 
5 Balanced by the addition of 2200 mg sucrose. 
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Table 2 Brachial artery and biochemical parameters 
 
Parameters Baseline LP apple Baseline  HP apple 
FMD (% compared to basal diameter) 6.1 ± 3.9 4.5 ± 3.0 5.7± 4.2 3.9 ± 3.2 
Glyceryl trinitrate 
        (% compared to basal diameter) 15.6 ± 4.7 16.7 ± 4.3 16.1 ± 5.9 16.2 ± 6.1 
NOx (nM) 72.7 ± 23.4 88.7 ±  51.6 81.5 ± 27.1 77.8 ± 31.1 
     
Systolic blood pressure (mmHg) 120.0 ± 12.2 118.6 ± 10.0 119.0 ± 11.2 118.8 ± 8.1 
Diastolic blood pressure (mmHg) 76.1 ± 8.7 76.9 ± 7.5 76.7 ± 7.8 77.0 ± 7.5 
Pulse pressure (mmHg) 61.1 ± 9.5 60.1 ± 9.6 60.4 ± 7.6 60.2 ± 8.9 
     
Phloretin (nmol/mg creatinine) 0.04 ± 0.09 0.52 ± 0.67† 0.11 ± 0.35 0.78 ± 1.17‡ 
Glucose (mmol/L) 4.9 ± 0.4 5.1 ± 0.3 4.9 ± 0.5 5.1 ± 0.5 
Iron (µmol/L) 18.3 ±6.3 18.6 ± 5.7 18.2 ± 5.1 18.0 ± 4.3
CRP (mg/L) 0.98 ± 1.06 0.78 ± 0.53 1.14 ± 1.08 1.16 ± 1.25 
  
FRAP (µM Fe2+/mL) 1047 ± 125 1021 ± 121 1026 ± 102 1057 ± 147 
ORAC (103µmol Trolox equivalents/L) 14.1 ± 2.8 13.5 ± 2.5 14.1 ± 2.7 13.4 ± 2.4
Vitamin C (µM) 57.3 ± 14.1 65.8 ± 11.4‡ 59.3 ± 17.4 65.8 ± 14.9* 
Plasma Vit E (µM) 38.4 ± 5.8 37.3 ± 6.7 37.4 ± 6.0 36.6 ± 6.2 
Uric acid (µmol/L) 329 ± 85 316 ± 100 344 ± 47 321 ± 104 
     
Homocysteine (µmol/L) 11.3 ± 3.6 11.5 ± 4.6 12.1 ± 7.2 12.3 ± 7.8 
Total cholesterol  (mmol/L) 6.3 ± 0.7 6.3 ± 0.9 6.5 ± 0.7 6.4 ± 0.9 
Triglycerides  (mmol/L) 1.4 ± 0.7 1.4 ± 0.7 1.3 ± 0.5 1.4 ± 0.6 
LDL cholesterol (mmol/L) 4.3 ± 0.6 4.2 ± 0.7 4.5 ± 0,6 4.4 ± 0.7 
HDL cholesterol (mmol/L) 1.4 ± 0.4 1.4 ± 0.3 1.4 ± 0.3 1.3 ± 0.3 
APOA1  (g/L) 1.5 ± 0.3 1.5 ± 0.2 1.6 ± 0.2 1.5 ± 0.2
APOB  (g/L) 1.2 ± 0.2 1.2 ± 0.2 1.3 ± 0.2 1.2 ± 0.2 
ApoB/ApoA1 0.79 ± 0.25 0.82 ± 0.19 0.82 ±0.19 0.84 ± 0.21 
 
Data are means ± SD. * P < 0.05; † P < 0.01; ‡ P < 0.001 as compared to baseline.
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Figure legend 
 
Figure 1: Study protocol. Men were randomized and treated for 4 weeks with LP and HP lyophilized 
apples. Patients were studied four times (arrows): at baseline and at the end of each period. FMD: 
flow-mediated vasodilation.  
 
Figure 2: Effect of a one-month intervention with low polyphenol (LP) and high polyphenol (HP) 
apple varieties on flow-mediated vasodilation. Symbols represent individual subjects. Symbols on the 
left and right of each figure and brackets are means ± SD. 


